Gear Up for Stryker (SYK) Q4 Earnings: Wall Street Estimates for Key Metrics

Core Insights - Stryker (SYK) is expected to report quarterly earnings of $4.39 per share, reflecting a 9.5% increase year-over-year, with revenues projected at $7.13 billion, a 10.7% increase compared to the previous year [1] Earnings Projections - Analysts have revised the consensus EPS estimate for the quarter upward by 0.1% over the past 30 days, indicating a collective reassessment of projections [1][2] Revenue and Sales Estimates - Analysts predict 'Net Sales by Business- MedSurg and Neurotechnology' to be $4.53 billion, representing a year-over-year increase of 16.8% [4] - The average estimate for 'Net Sales by Geography- Orthopaedics' is $2.61 billion, indicating a 2.3% increase from the prior-year quarter [4] - 'Net Sales by Geography- Orthopaedics- Hips' is expected to reach $504.79 million, reflecting a 9% year-over-year change [5] - 'Net Sales by Geography- United States' is forecasted at $5.44 billion, suggesting an 11.5% increase year-over-year [6] Specific Sales Forecasts - 'Net Sales by Geography- Orthopaedics- United States' is estimated at $1.87 billion, indicating a 17.7% year-over-year change [6] - 'Net Sales by Geography- Orthopaedics- Trauma and Extremities- United States' is projected to be $828.44 million, reflecting an 11.4% increase from the year-ago quarter [6] - 'Net Sales by Geography- Orthopaedics- Knees- United States' is expected to reach $553.93 million, indicating an 8.8% year-over-year change [7] International Sales Estimates - 'Net Sales by Geography- International' is projected at $1.72 billion, reflecting a 10.2% increase year-over-year [5] - 'Net Sales by Geography- MedSurg and Neurotechnology- Neuro Cranial- International' is expected to be $118.93 million, indicating a decline of 21.8% from the prior-year quarter [8] - 'Net Sales by Geography- MedSurg and Neurotechnology- vascular- International' is estimated at $241.70 million, reflecting an 18.5% increase from the year-ago quarter [8] Market Performance - Stryker shares have shown a return of +0.2% over the past month, mirroring the Zacks S&P 500 composite's +0.2% change, with a Zacks Rank 3 (Hold) indicating expected performance in line with the overall market [10]